Steven H. Itzkowitz, M.D. is Professor of Medicine and Oncological Sciences, and Director of the GI Fellowship Program at the Icahn School of Medicine at Mount Sinai. He is past Chair of the Gastrointestinal Oncology Section of the American Gastroenterological Association, past President of the New York Gastroenterological Association, and immediate past Co-Chair of the New York Citywide Colon Cancer Control Coalition (C5). He is a recipient of a distinguished Jacobi Medallion from the Mount Sinai School of Medicine and a Gold Humanism Award.
Dr. Itzkowitz has served as a Study Section member for the National Cancer Institute, Veteran's Affairs Merit Review Board, Crohn's and Colitis Foundation of America, and US-Israel Binational Science Foundation, and as an editor of the International Journal of Colorectal Disease, and Gut and Liver, and associate editor of Inflammatory Bowel Diseases, Clinical Gastroenterology and Hepatology, and Gastric Cancer. He spearheaded efforts to secure NCI funding for the East Harlem Partnership for Cancer Awareness: a program based at Mount Sinai, designed to raise awareness in the East Harlem community regarding the risks and treatment for several common cancers including colon cancer.
Dr. Itzkowitz's research interests are in the field of gastrointestinal cancer. His laboratory conducts research into the microbiome of patients with inflammatory bowel disease (IBD). Clinical studies have focused on detecting and preventing colon cancer in inflammatory bowel disease, reducing disparities in colon cancer screening, and developing new non-invasive stool DNA tests for colon cancer.
In the News: Dr. Steven Itzkowitz was recently featured in INSIDE MOUNT SINAI for his work in increasing screening colonoscopy rates in NYC with the C5 Coalition.
Language
English
Position
PROFESSOR | Medicine, Gastroenterology, PROFESSOR | Oncological Sciences, PROFESSOR | Medical Education
Steven H. Itzkowitz, M.D. is Professor of Medicine and Oncological Sciences, and Director of the GI Fellowship Program at the Icahn School of Medicine at Mount Sinai. He is past Chair of the Gastrointestinal Oncology Section of the American Gastroenterological Association, past President of the New York Gastroenterological Association, and immediate past Co-Chair of the New York Citywide Colon Cancer Control Coalition (C5). He is a recipient of a distinguished Jacobi Medallion from the Mount Sinai School of Medicine and a Gold Humanism Award.
Dr. Itzkowitz has served as a Study Section member for the National Cancer Institute, Veteran's Affairs Merit Review Board, Crohn's and Colitis Foundation of America, and US-Israel Binational Science Foundation, and as an editor of the International Journal of Colorectal Disease, and Gut and Liver, and associate editor of Inflammatory Bowel Diseases, Clinical Gastroenterology and Hepatology, and Gastric Cancer. He spearheaded efforts to secure NCI funding for the East Harlem Partnership for Cancer Awareness: a program based at Mount Sinai, designed to raise awareness in the East Harlem community regarding the risks and treatment for several common cancers including colon cancer.
Dr. Itzkowitz's research interests are in the field of gastrointestinal cancer. His laboratory conducts research into the microbiome of patients with inflammatory bowel disease (IBD). Clinical studies have focused on detecting and preventing colon cancer in inflammatory bowel disease, reducing disparities in colon cancer screening, and developing new non-invasive stool DNA tests for colon cancer.
In the News: Dr. Steven Itzkowitz was recently featured in INSIDE MOUNT SINAI for his work in increasing screening colonoscopy rates in NYC with the C5 Coalition.
Language
English
Position
PROFESSOR | Medicine, Gastroenterology, PROFESSOR | Oncological Sciences, PROFESSOR | Medical Education
University of CA at San Francisco School of Medicine
Certifications
American Board of Internal Medicine
Awards
2013
Excellence in Teaching Award
Institute for Medical Education; Mount Sinai School of Medicine
2013
Patient Advocacy Award
East Harlem Health Outreach Project (EHHOP)
2012
Faculty Award
Arnold P. Gold Foundation for Humanism
2011
Academic Achievement Award (Senior Faculty)
Faculty Council, Mount Sinai School of Medicine
2008
Faculty Award
Alpha Omega Alpha Medical Honor Society, Mount Sinai School of Medicine
2004
Best Doctors
Castle Connolly and New York Magazine
Research
Laboratory investigation is exploring the profile of intestinal microbiota in patients with inflammatory bowel disease (IBD) who have primary sclerosing cholangitis - conditions that predispose to colon cancer.
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Healthfirst Medicare Advantage insurance: Effective , Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.
Feinstein IBD Clinical Center17 East 102nd Street, 5th Floor, New York, NY, 10029
1199 SEIU
AETNA - Commercial
AETNA - Medicare
CIGNA Healthcare
Centivo
Cigna - Medicare
EmblemHealth - GHI-PPO
EmblemHealth - HIP
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Commercial/Exchange
Empire Blue Cross Blue Shield - Medicare
Horizon NJ
Hotel Trades
Humana Medicare
Magnacare-Health Care
Medicare - NJ
Medicare - NY
Multiplan PHCS
Oscar
Oxford - Freedom and Liberty
Partners Health Plan
Senior Whole Health
United Health Care - Commercial
United Health Care - Empire Plan
United Health Care - Oxford Care
United Health Care - Top Tier
VNSNY Choice Medicare
VillageCareMax
WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
5 out of 5
Care Provider’s Concern
5 out of 5
Likelihood to Recommend Care Provider
4.9 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Itzkowitz during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Exact Sciences Corporation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Show More
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Itzkowitz during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Exact Sciences Corporation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.